Arabic Arabic English English French French German German
dark

Abstract for MIV-818 phase 1b monotherapy for ESMO Congress published

Medivir AB announced that the Abstract entitled “Phase 1 study of the novel prodrug MIV-818 in patients with hepatocellular carcinoma, intrahepatic cholangiocarcinoma or liver metastases ” has been released on the European Society for Medical Oncology website. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment

Next Post

Biovica Provides Update on FDA Application Process

Related Posts
Total
0
Share